Brain Iron Accumulation in Neurological Diseases & Its Removal by Iron Chelation
(London Iron Metabolism Group)
Wednesday 21st May 2014 14:00-18:30
King’s College London
Franklin Wilkins Building, Classroom 3.52,
Stamford Street, London. SE1 9NH
Chairs: A McKie & D. Dexter
14:00-14:30 David Dexter (Imperial College London, UK)
A pilot efficacy and safety study with Deferiprone in Parkinson’s disease.
14:30-15:00 Joanna Collingwood (University of Warwick, UK)
Iron determinations in post-mortem brain and utilising MRI in Parkinson’s related disorders.
15:00-15:30 David Devos (Lille University, France)
Targeting chelatable iron as a therapeutic option in the treatment of Parkinson’s Disease.
16:00-16:30 John Connelly & Michael Spino (ApoPharma Inc, Canada)
The hydroxypyridinone dosing dilemma in neurodegeneration.
16:30-17:00 James Duce (University of Leeds, UK)
Role of APP in iron metabolism and neurodegeneration.
17:00-17:30 Kailash Bhatia (Institute of Neurology, University College London, UK)
Pathophysiology of neurodegeneration with brain iron accumulation (NBIA).
18:00 General Discussion
To reserve your place please contact: Andy McKie (Andrew.firstname.lastname@example.org)